Rheumatoid arthritis is generally regarded as a non-fatal disease, Although there is evidence that paatients with the disease have a diminished life expectancy, the causes of death are, by and large, the same as those in the general population. Although patients do die from complications of rheumatoid arthritis, these complications constitute only a small proportion of deaths. In our centre we have been interested in the complications of anti-rhematic drug therapy. In a previous study we found that these drugs constituted a significant morbidity among patients with rheumatoid arthritis, and 6% of admissions to hospital were due to complications of therapy, especially corticosteroid therapy
To update the evidence for the safety of synthetic disease-modifying antirheumatic drugs (sDMARDs), ...
AbstractA question is raised about an increased risk of severe infection from the use of biological ...
Introduction: Biologicals are a fast expanding group of new drugs and rituximab (RTX) is one of them...
While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents...
A questionnaire designed to ascertain the risk of adverse effects which patients with rheumatic cond...
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infe...
Introduction: The development of biologic therapies has been an enormous leap in the management of p...
BACKGROUND Drug therapy for rheumatic diseases has changed fundamentally in recent decades with t...
Background: The introduction of biological agents into the clinical armamentarium has modified the m...
Catalin O Codreanu,1 Nemanja Damjanov2 1Rheumatology Department, Center of Rheumatic Diseases, Bucha...
The disease R A itself is assumed to be a risk factor for the occurrence of adverse drug reactions d...
Immunomodulatory therapy for rheumatoid arthritis (RA) carries risk for infectious complications. Un...
Clinical manifestations of most rheumatic diseases have changed over the past few decades, largely d...
Objective Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in Sweden ...
Rheumatoid arthritis, often referred to as RA, is a long-term condition that mainly affects the join...
To update the evidence for the safety of synthetic disease-modifying antirheumatic drugs (sDMARDs), ...
AbstractA question is raised about an increased risk of severe infection from the use of biological ...
Introduction: Biologicals are a fast expanding group of new drugs and rituximab (RTX) is one of them...
While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents...
A questionnaire designed to ascertain the risk of adverse effects which patients with rheumatic cond...
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infe...
Introduction: The development of biologic therapies has been an enormous leap in the management of p...
BACKGROUND Drug therapy for rheumatic diseases has changed fundamentally in recent decades with t...
Background: The introduction of biological agents into the clinical armamentarium has modified the m...
Catalin O Codreanu,1 Nemanja Damjanov2 1Rheumatology Department, Center of Rheumatic Diseases, Bucha...
The disease R A itself is assumed to be a risk factor for the occurrence of adverse drug reactions d...
Immunomodulatory therapy for rheumatoid arthritis (RA) carries risk for infectious complications. Un...
Clinical manifestations of most rheumatic diseases have changed over the past few decades, largely d...
Objective Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in Sweden ...
Rheumatoid arthritis, often referred to as RA, is a long-term condition that mainly affects the join...
To update the evidence for the safety of synthetic disease-modifying antirheumatic drugs (sDMARDs), ...
AbstractA question is raised about an increased risk of severe infection from the use of biological ...
Introduction: Biologicals are a fast expanding group of new drugs and rituximab (RTX) is one of them...